![]() |
Volumn 106, Issue 1, 2002, Pages 80-86
|
Role of antiretroviral regimes in HIV-1 patients in reducing immune activation
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIRETROVIRUS AGENT;
CD4 ANTIGEN;
FAS ANTIGEN;
PROTEINASE INHIBITOR;
RNA DIRECTED DNA POLYMERASE INHIBITOR;
APOPTOSIS;
ARTICLE;
CELL CULTURE;
CLINICAL ARTICLE;
CONTROLLED STUDY;
FEMALE;
HUMAN;
HUMAN CELL;
HUMAN IMMUNODEFICIENCY VIRUS 1;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
LYMPHOCYTE ACTIVATION;
LYMPHOCYTE PROLIFERATION;
MALE;
MEMORY CELL;
PRIORITY JOURNAL;
PROTEIN BLOOD LEVEL;
T LYMPHOCYTE;
VIRUS LOAD;
ADULT;
ANTI-HIV AGENTS;
ANTIGENS, CD95;
ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE;
APOPTOSIS;
CD4 LYMPHOCYTE COUNT;
CELL DIVISION;
FEMALE;
HIV INFECTIONS;
HIV-1;
HUMANS;
LYMPHOCYTE ACTIVATION;
MALE;
MIDDLE AGED;
PHYTOHEMAGGLUTININS;
PROTEASE INHIBITORS;
VIRAL LOAD;
|
EID: 0036232966
PISSN: 00192805
EISSN: None
Source Type: Journal
DOI: 10.1046/j.1365-2567.2002.01399.x Document Type: Article |
Times cited : (3)
|
References (23)
|